Author:
Yang Rong,Ren Shuang,Jin Xiaowei,Sun Yu,Dong Yanli,Zhang Jinwei,Liang Wenzhong,Chen Li
Funder
Hua Medicine (Shanghai) Ltd.
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference17 articles.
1. Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study;Zhu;Lancet Diabetes Endocrinol.,2018
2. Safety, tolerability, pharmacokinetics, and pharmacodynamics of novel glucokinase activator HMS5552: results from a first-in-human single ascending dose study;Xu;Drug Des. Devel. Ther.,2016
3. The clinical relevance of plasma protein binding changes;Roberts;Clin. Pharmacokinet.,2013
4. Influence of plasma protein binding on pharmacodynamics: estimation of in vivo receptor affinities of β blockers using a new mechanism-based PK-PD modelling approach;Steeg;J. Pharm. Sci.,2009
5. Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples;Xu;Bioanalysis.,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献